These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 6145363)

  • 21. The first double-blind, placebo-controlled trial of a partial benzodiazepine agonist, abecarnil (ZK 112-119), in generalized anxiety disorder.
    Ballenger JC; McDonald S; Noyes R; Rickels K; Woods SW; Patin J; Lydiard B; Garvey M; Cook B; Goodard AW
    Adv Biochem Psychopharmacol; 1992; 47():431-47. PubMed ID: 1354920
    [No Abstract]   [Full Text] [Related]  

  • 22. Failure of buspirone to manage benzodiazepine withdrawal.
    Schweizer E; Rickels K
    Am J Psychiatry; 1986 Dec; 143(12):1590-2. PubMed ID: 2878622
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and withdrawal of two potent benzodiazepines: bromazepam and lorazepam.
    Fontaine R; Annable L; Beaudry P; Mercier P; Chouinard G
    Psychopharmacol Bull; 1985; 21(1):91-2. PubMed ID: 2858908
    [No Abstract]   [Full Text] [Related]  

  • 24. A comparison between bromazepam (Ro 5-3350, Lexotan) and diazepam (Valium) in anxiety neurosis. A controlled, double-blind clinical trial.
    Sonne LM; Holm P
    Int Pharmacopsychiatry; 1975; 10(2):125-8. PubMed ID: 237849
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The comparison of tianeptine and carbamazepine in benzodiazepines withdrawal symptoms].
    Kornowski J
    Psychiatr Pol; 2002; 36(6 Suppl):311-8. PubMed ID: 12647454
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of clorazepate on depressed mood in anxious patients.
    Zung WW
    J Clin Psychiatry; 1987 Jan; 48(1):13-4. PubMed ID: 2879832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abecarnil for the treatment of generalized anxiety disorder: a placebo-controlled comparison of two dosage ranges of abecarnil and buspirone.
    Pollack MH; Worthington JJ; Manfro GG; Otto MW; Zucker BG
    J Clin Psychiatry; 1997; 58 Suppl 11():19-23. PubMed ID: 9363044
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and tolerance of alprazolam and bromazepam in flexible doses. Double-blind study in 119 ambulatory anxious patients].
    Ropert R; Bernes J; Dachary JM
    Encephale; 1987; 13(2):89-95. PubMed ID: 2885173
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Comparative double-blind study of bromazepam versus prazepam in non-psychotic anxiety].
    Guelfi JD; Lancrenon S; Millet V
    Encephale; 1993; 19(5):547-52. PubMed ID: 8306923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New concepts in benzodiazepine therapy: rebound anxiety and new indications for the more potent benzodiazepines.
    Chouinard G; Labonte A; Fontaine R; Annable L
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):669-73. PubMed ID: 6141609
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A controlled trial of diazepam withdrawal in chronically anxious outpatients.
    Laughren TP; Battey Y; Greenblatt DJ; Harrop DS
    Acta Psychiatr Scand; 1982 Mar; 65(3):171-9. PubMed ID: 7072511
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Assessment of afobazole effects on diazepam withdrawal-induced anxiety in rats].
    Eksp Klin Farmakol; 2014; 77(4):6-9. PubMed ID: 25076752
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anxiolytic efficacy of alprazolam compared to diazepam and placebo.
    Maletzky BM
    J Int Med Res; 1980; 8(2):139-43. PubMed ID: 6102940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Bromazepam withdrawal delirium - a psychopharmacological contribution to clinical withdrawal syndromes (author's transl)].
    Böning J
    Nervenarzt; 1981 May; 52(5):293-7. PubMed ID: 6113557
    [No Abstract]   [Full Text] [Related]  

  • 37. A controlled clinical trial of alprazolam for the treatment of anxiety.
    Rickels K; Csanalosi I; Greisman P; Cohen D; Werblowsky J; Ross HA; Harris H
    Am J Psychiatry; 1983 Jan; 140(1):82-5. PubMed ID: 6128927
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ineffectiveness of clonidine in the treatment of the benzodiazepine withdrawal syndrome: report of three cases.
    Goodman WK; Charney DS; Price LH; Woods SW; Heninger GR
    Am J Psychiatry; 1986 Jul; 143(7):900-3. PubMed ID: 2872826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromazepam, a new anxiolytic: a comparative study with diazepam in general practice. Royal College of General Practitioners Medicines Surveillance Organisation.
    Royal College of General Practitioners Medicines Surveillance Organisation
    J R Coll Gen Pract; 1984 Sep; 34(266):509-12. PubMed ID: 6147412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.